A Genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology

Cell Reports

Volumn 10, Issue 4, 2015, Pages 633-644

  Matarin, Mar ^a,c   Salih, Dervis A ^b   Yasvoina, Marina ^b   Cummings, Damian M ^b   Guelfi, Sebastian ^c   Liu, Wenfei ^b   NahabooSolim, Muzammil A ^a,b   Moens, Thomas G ^b   Paublete, Rocio Moreno ^b   Ali, Shabinah S ^b   Perona, Marina ^a   Desai, Roshni ^a   Smith, Kenneth J ^a   Latcham, Judy ^d   Fulleylove, Michael ^d   Richardson, Jill C ^d   Hardy, John ^c   Edwards, Frances A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; TAU PROTEIN;

AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DATABASE; HIPPOCAMPUS; MALE; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RISK FACTOR; TAUOPATHY; TRANSGENIC MOUSE; TREM2 GENE; ANIMAL; BRAIN; DEMENTIA; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; METABOLISM;

MUS; MUS MUSCULUS;

ANIMALS; BRAIN; DEMENTIA; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; TAU PROTEINS;

EID: 84922803823     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.12.041     Document Type: Article

References (33)

1. Barabási A.L., Oltvai Z.N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004, 5:101-113.
2. Dickey C.A., Loring J.F., Montgomery J., Gordon M.N., Eastman P.S., Morgan D. Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein+ presenilin-1 transgenic mice. J.Neurosci. 2003, 23:5219-5226.
3. Driscoll I., Troncoso J.C., Rudow G., Sojkova J., Pletnikova O., Zhou Y., Kraut M.A., Ferrucci L., Mathis C.A., Klunk W.E., et al. Correspondence between invivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques. Acta Neuropathol. 2012, 124:823-831.
4. Frank S., Burbach G.J., Bonin M., Walter M., Streit W., Bechmann I., Deller T. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 2008, 56:1438-1447.
5. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 1998, 152:307-317.
6. Ghai R., Waters P., Roumenina L.T., Gadjeva M., Kojouharova M.S., Reid K.B., Sim R.B., Kishore U. C1q and its growing family. Immunobiology 2007, 212:253-266.
7. Guerreiro R.J., Hardy J. Alzheimer's disease genetics: lessons to improve disease modelling. Biochem. Soc. Trans. 2011, 39:910-916.
8. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., et al. TREM2 variants in Alzheimer's disease. N.Engl. J. Med. 2013, 368:117-127. Alzheimer Genetic Analysis Group.
9. Hartmann D., De Strooper B., Saftig P. Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr. Biol. 1999, 9:719-727.
10. Horvath S., Zhang B., Carlson M., Lu K.V., Zhu S., Felciano R.M., Laurance M.F., Zhao W., Qi S., Chen Z., et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl. Acad. Sci. USA 2006, 103:17402-17407.
11. Howlett D.R., Richardson J.C. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?. Histol. Histopathol. 2009, 24:83-100.
12. Howlett D.R., Bowler K., Soden P.E., Riddell D., Davis J.B., Richardson J.C., Burbidge S.A., Gonzalez M.I., Irving E.A., Lawman A., et al. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease. Histol. Histopathol. 2008, 23:67-76.
13. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
14. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N.Engl. J. Med. 2013, 368:107-116.
15. Lagraoui M., Latoche J.R., Cartwright N.G., Sukumar G., Dalgard C.L., Schaefer B.C. Controlled cortical impact and craniotomy induce strikingly similar profiles of inflammatory gene expression, but with distinct kinetics. Front Neurol 2012, 3:155.
16. Langfelder P., Zhang B., Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 2008, 24:719-720.
17. Manook A., Yousefi B.H., Willuweit A., Platzer S., Reder S., Voss A., Huisman M., Settles M., Neff F., Velden J., et al. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS ONE 2012, 7:e31310.
18. Merino-Serrais P., Benavides-Piccione R., Blazquez-Llorca L., Kastanauskaite A., Rábano A., Avila J., DeFelipe J. The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease. Brain 2013, 136:1913-1928.
19. Miller J.A., Cai C., Langfelder P., Geschwind D.H., Kurian S.M., Salomon D.R., Horvath S. Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics 2011, 12:322.
20. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1992, 1:345-347.
21. Oldham M.C., Horvath S., Geschwind D.H. Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc. Natl. Acad. Sci. USA 2006, 103:17973-17978.
22. Reddy P.H., McWeeney S., Park B.S., Manczak M., Gutala R.V., Partovi D., Jung Y., Yau V., Searles R., Mori M., Quinn J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum. Mol. Genet. 2004, 13:1225-1240.
23. Richardson J.C., Kendal C.E., Anderson R., Priest F., Gower E., Soden P., Gray R., Topps S., Howlett D.R., Lavender D., et al. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease. Neuroscience 2003, 122:213-228.
24. Stein T.D., Johnson J.A. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J.Neurosci. 2002, 22:7380-7388.
25. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
26. Thal D.R., Del Tredici K., Braak H. Neurodegeneration in normal brain aging and disease. Sci. SAGE KE 2004, 2004:pe26.
27. Trabzuni D., Ryten M., Walker R., Smith C., Imran S., Ramasamy A., Weale M.E., Hardy J. Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J.Neurochem. 2011, 119:275-282.
28. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:H0034.
29. Varki A., Geschwind D.H., Eichler E.E. Explaining human uniqueness: genome interactions with environment, behaviour and culture. Nat. Rev. Genet. 2008, 9:749-763.
30. Wirz K.T., Bossers K., Stargardt A., Kamphuis W., Swaab D.F., Hol E.M., Verhaagen J. Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model. Neurobiol. Aging 2013, 34:1328-1342.
31. Wu Z.L., Ciallella J.R., Flood D.G., O'Kane T.M., Bozyczko-Coyne D., Savage M.J. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol. Aging 2006, 27:377-386.
32. Yip A.M., Horvath S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics 2007, 8:22.
33. Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005, 4:e17.